Found: 120
Select item for more details and to access through your institution.
Setting the stage: host invasion by HIV.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00514-9
- By:
- Publication type:
- Article
Persistent serum protein signatures define an inflammatory subcategory of long COVID.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38682-4
- By:
- Publication type:
- Article
Corrigendum: OMIP‐056: Evaluation of Human Conventional T Cells, Donor‐Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining.
- Published in:
- Cytometry. Part A, 2020, v. 97, n. 2, p. 199, doi. 10.1002/cyto.a.23962
- By:
- Publication type:
- Article
OMIP‐056: Evaluation of Human Conventional T Cells, Donor‐Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining.
- Published in:
- Cytometry. Part A, 2019, v. 95, n. 7, p. 722, doi. 10.1002/cyto.a.23753
- By:
- Publication type:
- Article
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0202753
- By:
- Publication type:
- Article
Cryopreservation of human mucosal tissues.
- Published in:
- PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0200653
- By:
- Publication type:
- Article
The Pharmacokinetics and Serum and Urine Bactericidal Activity of Ciprofloxacin.
- Published in:
- 1985
- By:
- Publication type:
- Other
Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 11, p. 1, doi. 10.1371/journal.ppat.1006703
- By:
- Publication type:
- Article
Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 1, p. 1, doi. 10.1002/cti2.1360
- By:
- Publication type:
- Article
SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1347926
- By:
- Publication type:
- Article
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 519, p. 1, doi. 10.1126/scitranslmed.aaw1673
- By:
- Publication type:
- Article
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 419, p. 1, doi. 10.1126/scitranslmed.aan8848
- By:
- Publication type:
- Article
Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 2, p. 1, doi. 10.1371/journal.ppat.1004658
- By:
- Publication type:
- Article
HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 6, p. 1, doi. 10.1371/journal.ppat.1003404
- By:
- Publication type:
- Article
Response to Guo et al.'s Letter to the Editor.
- Published in:
- 2019
- By:
- Publication type:
- letter
Rank-based two-sample tests for paired data with missing values.
- Published in:
- 2018
- By:
- Publication type:
- journal article
COVID-19 and the Path to Immunity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms.
- Published in:
- European Journal of Human Genetics, 2005, v. 13, n. 6, p. 707, doi. 10.1038/sj.ejhg.5201409
- By:
- Publication type:
- Article
In situ detection of Gag-specific CD8+ cells in the GI tract of SIV infected Rhesus macaques.
- Published in:
- Retrovirology, 2010, v. 7, p. 12, doi. 10.1186/1742-4690-7-12
- By:
- Publication type:
- Article
Mucosal effects of tenofovir 1% gel.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.04525.001
- By:
- Publication type:
- Article
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08854-2
- By:
- Publication type:
- Article
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274906
- By:
- Publication type:
- Article
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-57491-z
- By:
- Publication type:
- Article
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0108631
- By:
- Publication type:
- Article
The Inner Foreskin of Healthy Males at Risk of HIV Infection Harbors Epithelial CD4+ CCR5+ Cells and Has Features of an Inflamed Epidermal Barrier.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0108954
- By:
- Publication type:
- Article
HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101863
- By:
- Publication type:
- Article
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043396
- By:
- Publication type:
- Article
A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0042163
- By:
- Publication type:
- Article
Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0033969
- By:
- Publication type:
- Article
Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028632
- By:
- Publication type:
- Article
Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024517
- By:
- Publication type:
- Article
A Phase IIA Randomized Clinical Trial of a Multiclade HIV- 1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204).
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0021225
- By:
- Publication type:
- Article
Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020479
- By:
- Publication type:
- Article
Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018526
- By:
- Publication type:
- Article
Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0015639
- By:
- Publication type:
- Article
Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013916
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054).
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013579
- By:
- Publication type:
- Article
Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0011995
- By:
- Publication type:
- Article
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 5, p. 1230
- By:
- Publication type:
- Article
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 310, doi. 10.1086/514209
- By:
- Publication type:
- Article
Cytotoxic T Cell and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Envelope with a Combination Vaccine Regimen.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 301, doi. 10.1086/514202
- By:
- Publication type:
- Article
Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus-Uninfected Recipients of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 4, p. 764
- By:
- Publication type:
- Article
Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with ⩾400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 2, p. 247
- By:
- Publication type:
- Article
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 340
- By:
- Publication type:
- Article
Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 4, p. 782
- By:
- Publication type:
- Article
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge.
- Published in:
- PLoS Pathogens, 2023, v. 18, n. 5, p. 1, doi. 10.1371/journal.ppat.1011051
- By:
- Publication type:
- Article